InsiderTrades.com logo

SER Insider Trading

Insider Ownership Percentage: 17.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $153,775.00

Serina Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Serina Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Serina Therapeutics Share Price & Price History

Current Price: $2.54
Price Change: ▲ Price Increase of +0.06 (2.42%)
As of 03/20/2026 05:10 PM ET

This chart shows the closing price history over time for SER up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Serina Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/19/2026Randall MoreadithInsiderSell39,000$2.50$97,500.00View SEC Filing Icon  
2/2/2026Randall MoreadithInsiderSell6,500$3.03$19,695.00View SEC Filing Icon  
1/28/2026Randall MoreadithInsiderSell6,500$3.57$23,205.00View SEC Filing Icon  
1/22/2026Randall MoreadithInsiderSell2,500$2.95$7,375.00View SEC Filing Icon  
1/21/2026Randall MoreadithInsiderSell2,000$3.00$6,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Serina Therapeutics (NYSEAMERICAN:SER)

12.50% of Serina Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Serina Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2026Broadwood Capital Inc.54,484$0.10M0.0%-34.5%0.505%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Read More on Serina Therapeutics

Today's Range

Now: $2.54
Low: $2.40
High: $3.00

50 Day Range

MA: $2.08
Low: $1.28
High: $3.54

52 Week Range

Now: $2.54
Low: $1.22
High: $7.92

Volume

13,261,162 shs

Average Volume

8,291,772 shs

Market Capitalization

$27.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

Who are the company insiders with the largest holdings of Serina Therapeutics?

Serina Therapeutics' top insider shareholders include:
  1. Randall Moreadith (Insider)
Learn More about top insider investors at Serina Therapeutics.

Who are the major institutional investors of Serina Therapeutics?

Serina Therapeutics' top institutional investors include:
  1. Broadwood Capital Inc. — 0.50%
Learn More about top institutional investors of Serina Therapeutics stock.

Which institutional investors are selling Serina Therapeutics stock?

In the previous quarter, SER stock was sold by these institutional investors:
  1. Broadwood Capital Inc.